切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2024, Vol. 18 ›› Issue (01) : 56 -57. doi: 10.3877/cma.j.issn.1674-0793.2024.01.010

病例报告

糖尿病性乳腺病二例诊疗分析
胡会元, 陈飞, 王克, 吴巍()   
  1. 225000 扬州大学附属医院普外科;116044 大连医科大学
    225000 扬州大学附属医院普外科
  • 收稿日期:2023-04-21 出版日期:2024-02-01
  • 通信作者: 吴巍

Diagnosis and treatment of diabetic mastopathy: two case reports

Huiyuan Hu, Fei Chen, Ke Wang   

  • Received:2023-04-21 Published:2024-02-01
引用本文:

胡会元, 陈飞, 王克, 吴巍. 糖尿病性乳腺病二例诊疗分析[J]. 中华普通外科学文献(电子版), 2024, 18(01): 56-57.

Huiyuan Hu, Fei Chen, Ke Wang. Diagnosis and treatment of diabetic mastopathy: two case reports[J]. Chinese Archives of General Surgery(Electronic Edition), 2024, 18(01): 56-57.

例1女,58岁,主诉发现右乳肿块1年,无疼痛、乳头溢液溢血,局部皮肤无红肿、破溃,乳腺钼靶示右乳头后上方见不对称致密影,BI-RADS Ⅳa级;乳腺彩超示右侧乳腺10点钟方向乳腺组织全层腺体组织紊乱,范围32.0 mm×32.0 mm×14.0 mm(L/W/H),方位与皮肤平行,纵横比<1,边缘欠光滑,内部未见明显钙化灶,BI-RADS Ⅳ级(图1)。既往有糖尿病病史10余年,平时血糖在13~20 mmol/L,口服二甲双胍0.85 qd、格列齐特30 mg、沙格列汀5 mg qd,血糖控制不佳。查体:双乳外观正常,大小对称,右乳10点钟方向可及一3.0 cm×3.0 cm大小肿块,质地偏硬,边界清晰,左乳未及异常,双侧腋下未及肿大淋巴结。入院后调整二甲双胍0.85 bid,排除手术禁忌,行乳房象限切除术,术中见右乳外上象限局部腺体质地硬,范围7.5 cm×6.0 cm,内含一枚小结节,大小约0.8 cm,质地韧,有弹性,边界清楚,包膜完整。术后常规病理报告:(1)大小:一7.5 cm×6.0 cm×3.0 cm灰白淡黄组织,部分已剖开,剖开处见一质硬区,切面灰白,大小2.5 cm×2.0 cm,局灶见一灰红结节,直径0.8 cm;(2)镜下:乳腺增生症,纤维腺瘤形成伴上皮增生活跃,部分导管扩张,间质见淋巴细胞浸润。未行免疫组织化学检测。患者于术后第2天顺利出院,术后3个月门诊复查乳腺彩超,未见肿块复发。

图1 乳腺彩超示右侧乳腺低回声结节 A为11点钟方向见一肿块,内部未见血流信号,BI-RADS Ⅳb级;B为10点钟方向见一肿块,提示回声不均,内部未见血流信号,BI-RADS Ⅳ级
图2 乳腺钼靶示右乳腺腺体分型为不均匀致密型,可见环形钙化 A为右乳轴位;B为内外斜位
图3 病例2组织病理图片(苏木精-伊红染色×10)
图4 病例2免疫组织化学图片(SP法×10)
[1]
Li AM, Erickson LA. Diabetic mastopathy[J]. Mayo Clin Proc, 2018, 93(9): 1334-1335.
[2]
Leroux-Stewart J, Rabasa-Lhoret R. Diabetic mastopathy: case report and summary of literature[J]. Can J Diabetes, 2014, 38(5): 305-306.
[3]
Agochukwu NB, Wong L. Diabetic mastopathy: A systematic review of surgical management of a rare breast disease[J]. Ann Plast Surg, 2017, 78(4): 471-475.
[4]
Camuto PM, Zetrenne E, Ponn T. Diabetic mastopathy: A report of 5 cases and a review of literature[J]. Arch Surg, 2000, 135(10): 1190-1193.
[5]
Francisco C, J lio C, Fontes AL, et al. Diabetic mastopathy: A case report[J]. Clin Imaging, 2012, 36(6): 829-832.
[6]
Kudva YC, Reynolds C, O’Brien T. Diabetic mastopathy, or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes[J]. Diabetes Care, 2002, 25(1): 121-126.
[7]
Sakuhara Y, Shinozaki T, Hozumi Y. MR imaging of diabetic mastopathy[J]. AJR Am J Roentgenol, 2002, 179(5): 1201-1203.
[8]
Wong KT, Tse GM, Yang WT. Ultrasound and MR imaging of diabetic mastopathy[J]. Clin Radiol, 2002, 57(8): 730-735.
[9]
Chan CL, Ho RS, Shek TW, et al. Diabetic mastopathy[J]. Breast J, 2013, 19(5): 533-538.
[10]
Guzik P, Gęca T, Topolewski P. Diabetic mastopathy. Review of diagnostic methods and therapeutic options[J]. Int J Environ Res Public Health, 2021, 19(1): 448.
[11]
Chou P, Choi HH, Huang Y, et al. Impact of diabetes on promoting the growth of breast cancer[J]. Cancer Commun (Lond), 2021, 41(5): 414-431.
[12]
Alkhudairi SS, Abdullah MM. Diabetic mastopathy in a patient with high risk of breast carcinoma: A management dilemmae[J]. Cureus, 2020, 12(2): e7003.
No related articles found!
阅读次数
全文


摘要